OTCMKTS:FLACU Frazier Lifesciences Acquisition (FLACU) Stock Price, News & Analysis $9.50 +0.23 (+2.48%) As of 11/22/2022 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Frazier Lifesciences Acquisition Stock (OTCMKTS:FLACU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get FLACU alerts:Sign Up Key Stats Today's Range$8.07▼$10.8050-Day Range$9.50▼$9.5052-Week Range$8.07▼$10.80Volume18,300 shsAverage Volume13,949 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington. Read More Receive FLACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Frazier Lifesciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address FLACU Stock News HeadlinesFrazier Life Sciences Appoints Gordon Empey as Chief Operating OfficerMay 1, 2025 | tmcnet.comGlycoMimetics Enters Into Acquisition Agreement With Crescent BiopharmaOctober 31, 2024 | stockhouse.comDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live.August 3 at 2:00 AM | American Alternative (Ad)GlycoMimetics enters acquisition agreement with Crescent BiopharmaOctober 29, 2024 | markets.businessinsider.comFrazier Lifesciences Acquisition Corporation (FLACU)August 5, 2022 | finance.yahoo.comNewAmsterdam Pharma Holding B.V. and Frazier Lifesciences Acquisition Corporation Announce Merger Agreement to Create Publicly Listed Company Focused on Transformative Oral Therapies for Major Cardiometabolic DiseasesJuly 25, 2022 | finance.yahoo.comAre Institutions Heavily Invested In Frazier Lifesciences Acquisition Corporation's (NASDAQ:FLAC) Shares?July 24, 2022 | finance.yahoo.comFrazier SPAC Is in Talks to Merge With NewAmsterdam PharmaJuly 19, 2022 | finance.yahoo.comSee More Headlines FLACU Stock Analysis - Frequently Asked Questions How have FLACU shares performed this year? Frazier Lifesciences Acquisition's stock was trading at $9.50 at the beginning of 2025. Since then, FLACU shares have increased by 0.0% and is now trading at $9.50. How do I buy shares of Frazier Lifesciences Acquisition? Shares of FLACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinancial Services Industry Shell Companies Sub-IndustryTrading Current SymbolOTCMKTS:FLACU CIK1828326 Webwww.frazierlifesciencesacquisition.com Phone206 621 7200FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:FLACU) was last updated on 8/3/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Frazier Lifesciences Acquisition Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Frazier Lifesciences Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
